Evaluation of botanicals as potential COVID-19 symptoms terminator
Open Access
- 21 October 2021
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 27 (39), 6551-6571
- https://doi.org/10.3748/wjg.v27.i39.6551
Abstract
Information about the coronavirus disease 2019 (COVID-19) pandemic is still evolving since its appearance in December 2019 and has affected the whole world. Particularly, a search for an effective and safe treatment for COVID-19 continues. Botanical mixtures contain secondary metabolites (such as flavonoids, phenolics, alkaloids, essential oils etc.) with many therapeutic effects. In this study, the use of herbal treatments against COVID-19 was evaluated. Medical synthetic drugs focus mainly on respiratory symptoms, however herbal therapy with plant extracts may be useful to relieve overall symptoms of COVID-19 due to the variety of bioactive ingredients. Since COVID-19 is a virus that affects the respiratory tract, the antiviral effects of botanicals/plants against respiratory viruses have been examined through clinical studies. Data about COVID-19 patients revealed that the virus not only affects the respiratory system but different organs including the gastrointestinal (GI) system. As GI symptoms seriously affect quality of life, herbal options that might eliminate these problems were also evaluated. Finally, computer modeling studies of plants and their active compounds on COVID-19 were included. In summary, herbal therapies were identified as potential options for both antiviral effects and control of COVID-19 symptoms. Further data will be needed to enlighten all aspects of COVID-19 pathogenesis, before determining the effects of plants on severe acute respiratory syndrome coronavirus 2.Keywords
This publication has 175 references indexed in Scilit:
- Curcumin Prevents Replication of Respiratory Syncytial Virus and the Epithelial Responses to It in Human Nasal Epithelial CellsPLOS ONE, 2013
- Inhibition of Enveloped Viruses Infectivity by CurcuminPLOS ONE, 2013
- Safety and Efficacy Profile ofEchinacea purpureato Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled TrialEvidence-Based Complementary and Alternative Medicine, 2012
- Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B virusesBMC Complementary and Alternative Medicine, 2011
- Effects of Green Tea Catechins and Theanine on Preventing Influenza Infection among Healthcare Workers: A Randomized Controlled TrialBMC Complementary and Alternative Medicine, 2011
- Viral Infections in Immunocompromised PatientsTransplantation and Cellular Therapy, 2011
- Activity of Melaleuca alternifolia (tea tree) oil on Influenza virus A/PR/8: Study on the mechanism of actionAntiviral Research, 2011
- Gastroprotective Effect of Ginger Rhizome(Zingiber officinale)Extract: Role of Gallic Acid and Cinnamic Acid in H+, K+-ATPase/H. pyloriInhibition and Anti-Oxidative MechanismEvidence-Based Complementary and Alternative Medicine, 2011
- The Diagnosis of Viral Respiratory Disease in Older AdultsClinical Infectious Diseases, 2010
- Elderberry flavonoids bind to and prevent H1N1 infection in vitroPhytochemistry, 2009